NVCR

NASD NovoCure Ltd.
Oct 13, 2026 · 5:49 AM ET LAST TRADE Market Closed

$14.72 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.72

YTD change
+13.84%
vs 20-day SMA
-6.32%
vs 200-day SMA
-0.33%

Price ranges

Previous day
$14.26 $14.76
open $14.54 close $14.72
+$0.18 (+1.24%)
Today
$0.00 $0.00
$14.72
Past week
$13.82 $15.88
from $15.20 now $14.72
-$0.48 (-3.16%)
Past month
$13.82 $16.99
from $16.22 now $14.72
-$1.50 (-9.25%)
This year
$9.82 $21.45
from $12.93 now $14.72
+$1.79 (+13.84%)

Price & Performance

+4.00 (+37.31%) / 6M

$9.98$13.56$17.15$20.73Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 93.7% away from all-time highs of $232.76
  • NVCR is up 14% since the beginning of the year
  • NVCR is up 11% over the past 12 months
  • NVCR is down 9% over the past 1 month
  • 11% of all NVCR investors are betting against NVCR

NVCR reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +11.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.13
Earnings momentum +44.6% Quarterly EPS growth
Quarterly change +44.6%

Valuation

P/E ratio N/A
Enterprise value $1.5B
Beta 2.25

Balance sheet & scale

IncomeN/A
Revenue$699.2M
Cash$450.5M
Debt$233.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.7B

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.21 +0.00%
ARGX argenx SE Sponsored ADR $812.30 -1.54%
ONC BeOne Medicines Ltd. Sponsored ADR $350.40 -1.15%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.55 -1.95%
INCY Incyte Corporation $111.36 -1.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.